Ultrasound assessment of the endometric in postmenopausal asymptomatic women using hormonal substitutions

This retrospective study evaluated endometrial thickness in 850 asymptomatic postmenopausal women (48–58 years; 2–3 years since menopause) undergoing annual preventive gynecologic examinations while using hormone substitutions, comparing Timbolone versus MF11RCE-yalouronic acid with transvaginal ultrasound. Endometrial thickness ≤6 mm was treated as normal, and women with thickness >6 mm were referred for diagnostic fractional abrasion combined with hysteroscopy. The authors reported that 33.6% had thickness <6 mm, 12.26% were between 5–7 mm, and 4.13% were ≥8 mm, and they found no statistically significant difference in thickness between the hormone groups. The study’s limitation is that it focused on thickness measurements and comparative ultrasound outcomes without providing detailed diagnostic pathology results in the provided text. Relevance to endometriosis: the paper is not centrally about endometriosis or adenomyosis; it was included in the corpus via a keyword match related to endometrial assessment in endometrial pathology risk contexts.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works